Prenetics Global Ltd. (PRE) Danny Yeung, CEO

A leading health

sciences company, is dedicated to advancing consumer and clinical health. Our

consumer initiatives is led by IM8, a new health and wellness brand. Our

clinical division is led by Insighta, our $200

million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection

technologies. This is followed by ACT Genomics, which has achieved FDA

clearance for comprehensive genomic profiling of solid tumors, and CircleDNA,

which uses NGS to offer comprehensive DNA tests. Each of Prenetics' units

synergistically enhances our global impact on health, embodying our commitment

to 'enhancing life through science'.

Next Episode All Episodes Previous Episode

Listen for free

RSS Feed Apple Podcasts Spotify Pocket Casts

About the Podcast

The Wall Street Resource

Your resource for microcap discovery and due diligence

As part of the investment process, we have conducted countless CEO and executive interviews, and found this to be an invaluable use of time. We provide The Wall Street Resource, not only to help you leverage your time, but for discovery and a starting point for due diligence.

About your host

Jeffrey Kone

Managing Member and portfolio manager of a micro-cap fund for over 15 years. Securities experience that encompasses almost all aspects of the industry (buy side, sell side, retail, institutional and investment banking). Degree from University of Southern California with a Bachelor of Science in Business, emphasis in Entrepreneurship.